Search for: "Gilead Sciences Limited" Results 1 - 20 of 84
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2019, 9:15 am by Steve Brachmann
"Based on feedback from partners and our work in the field, we believe that one of the greatest barriers to Truvada for PrEP access today is limited awareness of Truvada for PrEP’s role in HIV prevention," Gilead told IPWatchdog. [read post]
 However, having fought essentially the same undue burden issues before in Idenix v Gilead [2014] EWHC 3916 (Pat), it is unlikely Gilead felt they got two trials for the price of one! [read post]
2 Dec 2014, 7:35 am
 The judgment is available here on BAILII, and the case is properly called Idenix Pharmaceutical, Inc v Gilead Sciences, Inc & Ors [2014] EWHC 3916 (Pat) (01 December 2014).The technical field is treatments for Hepatitis C; the specific area is nucleoside analogues having alleged activity against Hepatitis C Virus and other viruses of the Flaviviridae family. [read post]
26 Sep 2018, 6:00 pm by Dennis Crouch
  Gilead Sciences, Inc., Docket No. 18-378 (Supreme Court 2018) In its newly filed petition for writ of certiorari, Merck asks one simple question: Whether the equitable defense of unclean hands precludes legal relief in the form of damages. [read post]
17 Jan 2019, 6:50 am by Anders Valentin
Anders ValentinGilead Sciences vs Sandoz – Round One The history of the case started in 2018, where Gilead Sciences Inc., brought preliminary injunctions before the court against several companies. [read post]
13 Aug 2008, 1:29 am
That is exactly what happened in the securities litigation involved Gilead Sciences. [read post]
18 Feb 2018, 8:52 am by Lawrence B. Ebert
Delaware overturned a $2.54 billion jury verdict against Gilead and instead ruled that Merck’s patent, asserted against hepatitis C drugs Sovaldi and Harvoni, was invalid.Of past events, see Merck wins $2.54 billion in hepatitis C drug trial against Gilead from 16 Dec 2016:Merck on Thursday was awarded $2.54 billion in royalties by a federal jury in a patent lawsuit against Gilead Sciences over Gilead's blockbuster hepatitis C drugs Sovaldi… [read post]
23 Mar 2010, 7:22 pm by Mark Bennett
But I’ve got all this investment in the idea that there’s balm in gilead. [read post]
2 Jul 2021, 3:30 am by Margo Bagley
Margo Bagley The 2018 Federal Circuit Gilead Sciences v. [read post]
7 Jul 2013, 9:33 am by Rajiv Kr. Choudhry
Usha Rao 2100/DEL/2007 GILEAD SCIENCES,INC. 25(1), Refused Hardev Karar 1135/DEL/2007 GILEAD SCIENCES, INC. 25(1), Refused Hardev Karar 3221/DELNP/2006 IBM Refused M Ravishankar 280/MUM/2005 TATA CHEMICALS LIMITED Refused N. [read post]
8 Apr 2016, 6:55 pm
Harvoni, developed by Gilead Sciences, Inc., is now viewed by doctors as a medically necessary treatment for Hepatitis C. [read post]